NCT01050816View on ClinicalTrials.gov

Effects of CHONDRON (Autologous Chondrocytes) With Ankle Cartilage Defect

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

February 28, 2009

Conditions
Articular Cartilage Defects of Ankle Joint
Interventions
PROCEDURE

Chondron(autologous chondrocyte) Implantation

"* Test drug: Chondron (more than 12 million chondrocytes in 0.4ml, i.e. 1 vial)~* Directions and dosage:~Suspend the cells in the vial sufficiently, and implant them in the defective part, making sure that sufficient amounts are injected.~\*30 subjects participated in this open clinical trial. Those who agreed to participate voluntarily went through screening to confirm the appropriateness for the clinical trial, and then received Gel type CHONDRON (fibrin mixed autologous chondrocytes) transplantation."

Trial Locations (1)

133831

Sewon Cellontech, Seoul

All Listed Sponsors
lead

Sewon Cellontech Co., Ltd.

INDUSTRY

NCT01050816 - Effects of CHONDRON (Autologous Chondrocytes) With Ankle Cartilage Defect | Biotech Hunter | Biotech Hunter